Advertisement

Skip to Content

Morningstar Moments: The Omicron Variant and Charitable Giving Strategies

The results are in: The best and worst new ETFs of 2021 list is live.

Carole Hodorowicz

Dec 3, 2021

1) The Omicron Sell-Off

https://twitter.com/LauricellaTom/status/1466145654028312578

As the newest strain of the coronavirus made headlines, it also pulled the stock market down from its record highs. Our outlook on leading vaccine-makers remains unchanged. However, our analysts found three wide-moat stocks that have just gone on sale. Check out these bargains now.

2) 'Tis the Season for Charitable Giving

https://twitter.com/christine_benz/status/1465711114809851913

The size of the donation is not what matters. Anyone can be a charitable giver, as explained by Christine Benz and Susan Dziubinski. Whether you’re contributing to charity through IRA assets or a donor-advised fund, here is how you can give back--and get a little something for yourself on your tax write-off.

3) The ETF World’s Class of 2021

https://twitter.com/MstarETFUS/status/1466147373479079937

This year alone, 406 new exchange-traded funds were launched. With the year wrapping up, Ben Johnson explored the crowded landscape to find the best and worst additions. Here's a quick tip: The hottest trend is not always the best investment.

Stay in the loop with @MorningstarInc and our analysts:
Tom Lauricella, editor for Morningstar Direct: @LauricellaTom
Christine Benz, director of personal finance: @christine_benz
Ben Johnson, director of global exchange-traded funds: @MstarETFUS

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.